Bourgoin, France: Oral solid dose development and manufacturing facility
Supporting early- and late-stage oral solid dose development and commercial manufacturing, with specialized capabilities for high-potency APIs.
Key highlights at our Bourgoin site
$9M investment provides 1000 MT of capacity, 300 to 3,000 L, GERTEIS MacroPactor WIP with gravity feed and contained product flow.
Supported 100+ OSD R&D projects across formulation, ASAP, and compaction simulation, with contained capabilities for dry and wet granulation, blending, and STYL’ONE EVO compaction.
Early formulation screening and development solutions for solubility and bioavailability enhancement, ranging from a few grams to 100 grams of high-potency API.
Our Bourgoin, France facility is a center of excellence specializing in the early- and late-stage development and commercial manufacturing of oral solid dose (OSD) products, with a particular focus on high-potency active pharmaceutical ingredients (APIs).
Early-stage oral solid dose development hub
This 490-square-meter dedicated R&D hub features state-of-the-art equipment and technologies to support formulation development and mature product characterization of oral solid dose forms. Our comprehensive capabilities enable customers to accelerate their time-to-market by facilitating smarter decision-making, minimizing experimental efforts, and reducing risks.
GMP pilot plant for programs of all sizes
Our 1,100-square-meter pilot plant is dedicated to process development and clinical trial manufacturing (1–120 kg) with available capacity to accommodate programs of various sizes. This state-of-the-art facility is designed to maximize safety, minimize cross-contamination risk, and improve operational efficiency through containment-at-source processes and separate material and personnel flows.
Specialized OSD capabilities in Bourgoin, France
- Specialization in handling highly potent APIs up to category 3B, including cytostatic
- Comprehensive packaging solutions including bottles, blisters, and high-speed lines
- Versatile manufacturing capabilities for tablets, capsules, powders, and granules with low relative humidity conditions
- Agile and flexible packaging solutions for multiple SKUs with online and offline blister printing lines, enabling low cost of goods and fast new product launches
- Capacity to support commercial supply from small scale (orphan/niche/pediatric) to large scale
This site has a strong regulatory inspection history with all major international regulatory agencies. Investments are made on an ongoing basis in both capital and scientific resources to enhance capabilities and equip customers with the latest technologies for OSD development and manufacturing.
To learn more about our specific equipment and capabilities, download our site fact sheet.
